Parker, W., Berek, J. S., Pritts, E., Olive, D., Kaunitz, A. M., Chalas, E., … DeLancey, J. (2016). An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. United States. https://doi.org/10.1016/j.jmig.2015.12.012

Parker, William, Jonathan S. Berek, Elizabeth Pritts, David Olive, Andrew M. Kaunitz, Eva Chalas, Daniel Clarke-Pearson, et al. “An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.” J Minim Invasive Gynecol, 2016. https://doi.org/10.1016/j.jmig.2015.12.012.

Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, et al. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. Vol. 23, J Minim Invasive Gynecol. 2016. p. 303–8.

Parker, William, et al. “An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas.” J Minim Invasive Gynecol, vol. 23, no. 3, 2016, pp. 303–08. Pubmed, doi:10.1016/j.jmig.2015.12.012.

Parker W, Berek JS, Pritts E, Olive D, Kaunitz AM, Chalas E, Clarke-Pearson D, Goff B, Bristow R, Taylor HS, Farias-Eisner R, Fader AN, Maxwell GL, Goodwin SC, Love S, Gibbons WE, Foshag LJ, Leppert PC, Norsigian J, Nager CW, Johnson T, Guzick DS, As-Sanie S, Paulson RJ, Farquhar C, Bradley L, Scheib SA, Bilchik AJ, Rice LW, Dionne C, Jacoby A, Ascher-Walsh C, Kilpatrick SJ, Adamson GD, Siedhoff M, Israel R, Paraiso MF, Frumovitz MM, Lurain JR, Al-Hendy A, Benrubi GI, Raman SS, Kho RM, Anderson TL, Reynolds RK, DeLancey J. An Open Letter to the Food and Drug Administration Regarding the Use of Morcellation Procedures in Women Having Surgery for Presumed Uterine Myomas. J Minim Invasive Gynecol. 2016. p. 303–308.